Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nu Skin Enterprises has signed a memorandum of understanding for a joint R&D relationship with Toyo Bio-Pharma, a subsidiary of Toyo Shinyaku, a natural products manufacturer with facilities in the US and Japan.
Subscribe to our email newsletter
To facilitate this relationship, the companies established a new joint venture, NU Toyo Research in the US.
The companies’ collaborative development efforts will focus on sharing scientific and regulatory insights, as well as developing proprietary nutraceutical and cosmeceutical products for Nu Skin sales through its worldwide distribution network.
Yoshi Shiraishi, president and COO of Toyo Bio-Pharma, said: “We expect this relationship with Nu Skin Enterprises to nicely complement our current expertise in natural health supplements. We believe there is a synergy between the two research teams that both companies can benefit from.”